New York, Oct. 12, 2017 -- According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing prevalence of diabetic neuropathy, government focus on creating awareness on diabetes cure, increasing global healthcare spending, rising demand for diabetic socks due to the increase in the prevalence of diabetes across the globe, and changes in lifestyle that increase the probability of genomic mutations. However, higher costs associated with diabetic socks and lack of awareness among people are some of the factors that will restrict revenue growth of the diabetic socks market over the forecast period.
Global Market Research Report Overview on Diabetic Socks @ https://www.persistencemarketresearch.com/market-research/diabetic-socks-market.asp
Global Diabetic Socks Market: Segmental Forecast
The market is segmented based on product type, material type, distribution channel and region. On the basis of product type the market has been segmented into regular socks and smart socks. By product type, the regular socks segment is expected to remain the largest segment, registering a CAGR of above 4% in terms of value during the forecast period. The regular socks product type segment is expected to reach a market value of US$ 192.8 Mn by 2025 end.
On the basis of material type, the diabetic socks market has been segmented as polyester, cotton, nylon, spandex, lycra and others. The others segment is expected to remain the largest segment, registering a CAGR of above 5% in terms of value over the forecast period. The others material type segment is expected to reach a market value of US$ 96.5 Mn by 2025 end.
A Sample of this report is available upon request@ https://www.persistencemarketresearch.com/samples/19282
On the basis of distribution channel, the global diabetic socks market has been segmented as retail stores, online stores, modern trade, pharmacies, clinics and other healthcare facilities. By distribution channel, the online stores segment is expected to remain the largest segment, registering a CAGR of above 6% in terms of value over the forecast period. The online stores segment is expected to reach a market value of US$ 61.1 Mn by 2025 end.
On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America is estimated to dominate the global diabetic socks market with maximum value share of the overall market recorded in 2016. The North America diabetic socks market is expected to register a CAGR of more than 4% over the forecast period to reach a market value of US$ 60.7 Mn by 2025 end.
View Report Table of Contents, Figures, and Tables@ https://www.persistencemarketresearch.com/market-research/diabetic-socks-market/toc
Global Diabetic Socks Market: Vendor Ecosystem
Some of the key players in the global diabetic socks market across the value chain are BSN Medical, Therafirm, SIGVARIS, SIMCAN ENTERPRISES INC, 3M, Veba Inc.,Siren care, Intersocks S.R.L, THORLO, Inc, Cupron and Cresswell Socks Mill. Companies are focusing on collaborating with established research centers to develop new products. The report also identifies company-specific strategies related to product development, market consolidation initiatives and analysis of companies’ specific strengths, weaknesses, opportunities and threats.
Global Diabetic Socks Market Report is Available for US$ 4,900
Persistence Market Research Overview
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
Persistence Market Research U.S. Sales Office: 305 Broadway, 7th Floor New York City, NY 10007 +1-646-568-7751 United States USA - Canada Toll-Free: 800-961-0353 Email: [email protected]


Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 



